These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6166801)

  • 1. Feline hypoxic pulmonary vasoconstriction is not blocked by the angiotensin I-converting enzyme inhibitor, captopril.
    Prewitt RL; Leffler CW
    J Cardiovasc Pharmacol; 1981; 3(2):293-8. PubMed ID: 6166801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin, hypoxia, verapamil and pulmonary vessels.
    Suggett AJ; Mohammed FH; Barer GR
    Clin Exp Pharmacol Physiol; 1980; 7(3):263-74. PubMed ID: 7398135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of angiotensin-converting enzyme inhibitor (captopril) on the mechanism of hypoxic pulmonary vasoconstriction. Experimental study in dogs].
    Soares GP; Romaldini H; dos Santos ML; Ratto OR
    Arq Bras Cardiol; 1989 Jun; 52(6):307-14. PubMed ID: 2557814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats.
    Russell PC; Emery CJ; Cai YN; Barer GR; Howard P
    Eur Respir J; 1990 Jul; 3(7):779-85. PubMed ID: 2261965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
    Wong PC; Zimmerman BG
    Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of pressor responses to angiotensin I, II, and III in pulmonary vascular bed of cats.
    Cheng DY; DeWitt BJ; McMahon TJ; Kadowitz PJ
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2247-55. PubMed ID: 8023987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.
    Kentera D; Susić D; Cvetković A; Djordjević G
    Basic Res Cardiol; 1981; 76(3):344-51. PubMed ID: 6455994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
    Morrell NW; Morris KG; Stenmark KR
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anesthesia alters pulmonary vasoregulation by angiotensin II and captopril.
    Nyhan DP; Chen BB; Fehr DM; Rock P; Murray PA
    J Appl Physiol (1985); 1992 Feb; 72(2):636-42. PubMed ID: 1559942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of captopril on pulmonary haemodynamics.
    Richard C; Ricome JL; Rimailho A; Conrad M; Auzépy P
    Eur J Clin Pharmacol; 1984; 27(1):35-9. PubMed ID: 6386489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor blockade and effects on pulmonary hemodynamics and hypoxic pulmonary vasoconstriction in humans.
    Kiely DG; Cargill RI; Lipworth BJ
    Chest; 1996 Sep; 110(3):698-703. PubMed ID: 8797414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylene blue prevents hypoxic pulmonary vasoconstriction in cats.
    Hyman AL; Lippton HL; Kadowitz PJ
    Am J Physiol; 1991 Feb; 260(2 Pt 2):H586-92. PubMed ID: 1671738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of captopril in hypoxic pulmonary hypertension. Comparison with transient oxygen administration.
    Boschetti E; Tantucci C; Cocchieri M; Fornari G; Grassi V; Sorbini CA
    Respiration; 1985; 48(4):296-302. PubMed ID: 3909277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vascular actions of the converting enzyme inhibitor, enalapril.
    Lefer DJ; Lefer AM
    Proc Soc Exp Biol Med; 1984 Feb; 175(2):211-4. PubMed ID: 6320208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of oxidative ATP production cause transient vasoconstriction and block subsequent pressor responses in rat lungs.
    Rounds S; McMurtry IF
    Circ Res; 1981 Mar; 48(3):393-400. PubMed ID: 7460212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intralipid on hypoxic and angiotensin-II induced pulmonary vasoconstriction in the isolated rat lung.
    Baudouin SV; Messent M; Evans TW
    Crit Care Med; 1994 Dec; 22(12):1964-8. PubMed ID: 7988134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril interferes with neurogenic vasoconstriction in the pithed rat by angiotensin-dependent mechanisms.
    Hatton R; Clough DP
    J Cardiovasc Pharmacol; 1982; 4(1):116-23. PubMed ID: 6176786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent effects of indomethacin on hypoxic vasoconstriction in neonatal lamb lungs.
    Gordon JB; Tod ML; Wetzel RC; McGeady ML; Adkinson NF; Sylvester JT
    Pediatr Res; 1988 Jun; 23(6):580-4. PubMed ID: 3393389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.
    Spertini F; Brunner HR; Waeber B; Gavras H
    Circ Res; 1981 May; 48(5):612-8. PubMed ID: 6260396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.